Randomized trial · people

Linaclotide: trend to more bowel movements in kids at higher doses

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In children with functional constipation, linaclotide was well tolerated over 4 weeks, with higher doses showing a trend toward more bowel movements.

Kind
Randomized trial
Studied in
People
Number studied
173
Published
2024
Journal
J Pediatr Gastroenterol Nutr

What they tested

The team tested how safe and effective several daily doses of linaclotide were in children aged 6 to 17 with functional constipation.

How the study was done

A multicenter, randomized, double-blind, placebo-controlled phase 2 trial in 173 children with functional constipation, given one of several daily linaclotide doses or a placebo (a dummy treatment) for 4 weeks. Children aged 6 to 11 got doses set by body weight, and those aged 12 to 17 got 18, 36, 72 or 145 μg.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The weekly number of spontaneous bowel movements improved more as the linaclotide dose went up. In 6- to 11-year-olds on the 36 or 72 μg arm, the mean weekly count rose by 1.90, and in 12- to 17-year-olds on the 72 μg arm it rose by 2.86. Of the 173 children, 162 (93.6%) finished the treatment period. Diarrhea was the most common side effect, mostly mild and never severe.

What it doesn’t show

This was a short 4-week phase 2 trial, and the gains were described as a numerical trend at the higher doses rather than a firm result. The researchers said the drug needs further study.

The paper

Di Lorenzo et al. Randomized controlled trial of linaclotide in children aged 6-17 years with functional constipation. J Pediatr Gastroenterol Nutr. 2024.

The compound

More studies on Linaclotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo